Indo Us Bio-Tech Limited (INDOUS) Fair Value & Analysis
Basic Materials · IN · Market cap ₹1.8B
Fair value as of: Jul 3, 2026
From 17 valuation models · updated yesterday
Share price −6.7% over the past month.
Price vs Fair Value (12 months)
12‑month range ₹86.75 – ₹196.08 · fair‑value band ₹60.42 – ₹139.07 · the ₹88.30 price screens below the ₹111.26 fair value. As of Jul 3, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Indo Us Bio-Tech Limited (INDOUS) currently trades at ₹88.30, while our model-based Fair Value estimate is ₹111.26 — implying the stock looks roughly 26.0% undervalued today. We read business quality at 40/100 (below-average quality), in the Basic Materials sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.
Over the trailing twelve months, Indo Us Bio-Tech Limited generated revenue of ₹1.1B at a net margin of 11.9%. Revenue declined 22.0% year over year. It earns a return on equity of 15.3%. Net debt stands at ₹309M. Fundamentals as of Jul 3, 2026
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jul 3, 2026. TTM = trailing twelve months.
About the company
Indo Us Bio-Tech Limited engages in the production, processing, packing, and marketing of seeds in India. The company offers vegetable seeds, such as tomato, okra, bottle gourd, brinjal, carrot, cluster bean, bitter gourd, ridge gourd, cucumber, cabbage, radish, sponge gourd, pepper, chilly, sweet pepper, beet root, cow pea, corriander, onion, watermelon, musk melon, and flower seeds; cotton seeds; and oil seeds, including castor, groundnut, sesamum, mustard, and soyabean seeds. It also provides cumin and isabgul spices seeds; pulses seeds comprising val, gram, black gram, and green gram seeds; and cereals seeds consisting of wheat, maize, bajra, and pegeon pea seeds. It also exports its products. The company was incorporated in 2004 and is based in Ahmedabad, India.
Revenue & earnings trend
FY2022 – FY2026 · reported fiscal years
Indo Us Bio-Tech Limited reported revenue of ₹1.1B in FY2026 versus ₹501M in FY2022, a compound +21.9%/yr. Reported net income was ₹131M in FY2026, compounding +26.9%/yr from FY2022.
Is INDOUS fairly valued? → Check now
Similar stocks
6 more Agricultural Inputs stocks, each showing price versus our Fair Value estimate (as of Jul 3, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Corteva, Inc CTVA | $77.46 | $39.29 | -49% |
| Nutrien Ltd NTR | $68.50 | $52.75 | -23% |
| Qinghai Salt Lake Industry Co 000792 | ¥30.69 | ¥21.26 | -31% |
| CF Industries Holdings C1FI34 | R$577.43 | R$978.53 | +69% |
| Yara International ASA YAR | kr 502.80 | kr 695.65 | +38% |
| ICL Group ICL | $5.07 | $2.88 | -43% |
Explore undervalued stocks
More undervalued Basic Materials stocks →
Frequently asked questions
Is Indo Us Bio-Tech Limited (INDOUS) undervalued?
What is the fair value of INDOUS?
What is the quality score of INDOUS?
What is the revenue of Indo Us Bio-Tech Limited (INDOUS)?
What is the net profit margin of INDOUS?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.